The report US HIV Market and Competitive Landscape Highlights - 2022, provides comprehensive insights into HIV pipeline products, HIV epidemiology, HIV market valuations and forecast, HIV drugs sales and competitive landscape in the US.
The research is classified into seven sections - HIV treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
The research is classified into seven sections - HIV treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
Research Scope:
- HIV pipeline: Find out the products in clinical trials for the treatment of HIV by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- HIV epidemiology: Find out the number of patients diagnosed (prevalence) with HIV in the US
- HIV drugs: Identify key products marketed and prescribed for HIV in the US, including trade name, molecule name, and company
- HIV drugs sales: Find out the sales revenues of HIV drugs in the US
- HIV market valuations: Find out the market size for HIV drugs in 2021 in the US. Find out how the market advanced from 2019 and forecast to 2027
- HIV drugs market share: Find out the market shares for key HIV drugs in the US
Benefits of this Research:
The research helps executives to- Support monitoring and reporting national HIV market analysis and sales trends
- Track competitor drugs sales and market share in the US HIV market
- Track competitive developments in HIV market and present key issues and learnings
- Synthesize insights for HIV market and products to drive business performance
- Answer key business questions about the HIV market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for HIV products
- Supports decision making in R&D to long term marketing strategies
Table of Contents
1) HIV Treatments2) HIV Pipeline
3) US HIV Epidemiology
4) Marketed Drugs for HIV in US
5) US HIV Market Size and Forecast
6) US HIV Products Sales and Forecast
7) US HIV Market Competitive Landscape
8) Methodology
9) Contact us
List of Tables
1. HIV Phase 3 Clinical Trials, 2022
2. HIV Phase 2 Clinical Trials, 2022
3. HIV Phase 1 Clinical Trials, 2022
4. HIV Epidemiology, US, 2021 - 2027
5. Marketed Drugs for HIV, US, 2021
6. HIV Market Size and Forecast ($), US, 2019 - 2027
7. HIV Drugs Sales ($), US, 2019 - 2027
List of Figures
1. HIV Epidemiology, US, 2021 - 2027
2. HIV Market Size and Forecast ($), US, 2019 - 2027
3. HIV Drugs Market Share (%), US, 2021
